Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
MK-7965
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Neuroblastoma (NB), the most common extracranial solid tumor of childhood, is responsible for approximately 15% of cancer-related… Expand
2015
2015
KRAS is activated by mutation in the vast majority of cases of pancreatic cancer; unfortunately, therapeutic attempts to inhibit… Expand
Highly Cited
2014
Highly Cited
2014
INTRODUCTION
Effective therapies after failure of treatment with anthracyclines and taxanes are needed for patients with… Expand
Highly Cited
2014
Highly Cited
2014
OBJECTIVES
Dinaciclib (MK-7965, formerly SCH 727965), a novel, small-molecule inhibitor of cyclin-dependent kinases, has been… Expand
Review
2014
Review
2014
Introduction: Cyclin-dependent kinases (CDK) represent attractive targets in oncology due to their key role in controlling gene… Expand
2013
2013
Objectives: Dinaciclib (MK-7965, formerly SCH 727965), a novel, small-molecule inhibitor of cyclindependent kinases, has been… Expand
Highly Cited
2012
Highly Cited
2012
After more than a decade of clinical development for cancer and numerous failures, Phase III trials of cyclin-dependent kinase… Expand